ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Appili to progress Phase III oral Covid-19 treatment trial
May 18, 2021Appili Therapeutics is set to continue its ongoing Phase III PRESECO trial of oral therapy, Avigan/Reeqonus (favipiravir), without modification to treat mild-to-moderate Covid-19. -
Appili Signs Grant Contract with DOD to Develop “Superbugs” Antibiotics
July 03, 2019Appili Therapeutics announced the United States Department of Defense, (DOD) Congressionally Directed Medical Research Programs, Peer Reviewed Medical Research Program (PRMRP) has completed the contract awarding the Company a $3.0 million USD grant.
Pharma Sources Insight January 2025
